New method for scheduling radiation therapy could be more effective at killing tumors

Researchers at the University of Waterloo have identified a new method for scheduling radiation therapy that could be as much as 22 percent more effective at killing cancer cells than current standard radiation treatment regimens.

While many mathematical studies have examined how to optimize the scheduling of radiation treatment for maximum effectiveness against cancer, most of these studies assume "intratumoral homogeneity" – that is, that all of the cancer cells are the same. In recent years, however, scientists have realized that tumors are made up of many different kinds of cells. Most importantly, they include cancer stem cells, which are more resistant to radiation than other kinds of cells.

The problem with any calculation involving cancer is that it's super hard to get exact values because things vary from cancer type to cancer type, patient to patient, even within the tumor."

Cameron Meaney, PhD Candidate in Applied Mathematics at Waterloo and Lead Researcher

This new algorithm can generalize the differing radiation resistances of stem cells and non-stem cells, allowing doctors to predict how a tumor will respond to treatment before gathering exact data on an individual's cancer.

The model has limitations, Meaney explained, as tumors contain far more than two kinds of cells. What it does, however, is provide clinical researchers with a better starting point for treatment research.

"The results of the algorithm are important because they shed light on the idea that heterogeneity in tumors matters for planning treatment," Meaney said.

The next step the researchers hope to see is an application of their algorithm to clinical studies: will their suggested therapy schedule outperform existing scheduling practices in a lab trial?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy